Federal Register / Vol. 62, No. 218 / Wednesday, November 12, 1997 / Notices 60723

water does not necessarily indicate that

the drinking water poses a health risk,

and that more information about

contaminants and potential health

effects can be obtained by calling the

EPA hotline.

What type of information about the

contents of bottled water could be

provided that would be analogous to the

previously described information

required in a CCR? For example,

because FDA establishes ‘‘allowable

levels’’ and not MCL’s for contaminants

in bottled water, would providing

information describing the term

‘‘allowable level’’ as established in

FDA’s quality standard regulation for

bottled water be analogous to the

provision of information about MCL’s

required in a CCR? Also, by way of an

example, for information concerning

MCLG’s, variances, exemptions that are

required in a CCR, are there similar or

analogous types of information with

respect to bottled water that could be

provided to customers?

IV. Comments

Interested persons may, on or before

December 12, 1997, submit to the

Dockets Management Branch (address

above) written comments regarding this

document. Two copies of any comments

are to be submitted, except that

individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday.

Dated: November 3, 1997.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 97–29655 Filed 11-10-97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Submission for OMB Review;

Comment Request; NLM Online

Application Packet

SUMMARY: In compliance with the

requirement of Section 3506(c)(2)(A) of

the Paperwork Reduction Act of 1995,

the National Library of Medicine (NLM),

the National Institutes of Health (NIH)

has submitted to the Office of

Management and Budget (OMB) a

request to review and approve the

information collection listed below.

This proposed information collection

was previously published in the Federal

Register on July 10, 1997, page number

37068, and allowed 60 days for public

comment. No public comments were

received. The purpose of this notice is

to allow an additional 30 days for public

comment. The National Institutes of

Health may not conduct or sponsor, and

the respondent is not required to

respond to, an information collection

that has been extended, revised, or

implemented on or after October 1,

1995, unless it displays a currently valid

OMB control number.

PROPOSED COLLECTION: Title: NLM

Online Application Packet. Type of

Information Collection Request:

Extension of OMB No. 0925–0223.

Expires 11/30/97. Need and Use of

Information Collection: The NLM uses

the information provided by individuals

and institutions for MEDLARS online

system user code assignments and

invoices for system use. Frequency of

Response: On occasion. Affected Public:

Individuals or households; businesses

or other for profit; State or local

governments; Federal agencies; Nonprofit institutions; Small businesses or

organizations. Type of Respondents:

Organizations, Health Care Providers,

Students. The annual reporting burden

is as follows: Estimated Number of

Respondents annually: 2,640. Estimated

Number of Responses per Respondent:

1; Average Burden Hours Per Response:

0.0833 hours; and Estimated Total

Annual Burden Hours Requested: 219.

The annualized cost to respondents is

estimated at: $11,383. There are no

capital costs to report. There are no

operating or maintenance costs to

report.

REQUEST FOR COMMENTS: Written

comments and/or suggestions from the

public and affected agencies are invited

on one or more of the following points:

(1) Whether the proposed collection of

information is necessary for the proper

performance of the function of the

agency, including whether the

information will have practical utility;

(2) The accuracy of the agency’s

estimate of the burden of the proposed

collection of information; (3) Ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) Ways to minimize the burden of the

collection of information on those who

are to respond, including the use of

appropriate automated, electronic,

mechanical, or other technological

collection techniques or other forms of

information technology.

DIRECT COMMENTS TO OMB: Written

comments and/or suggestions regarding

the items(s) contained in this notice,

especially regarding the estimated

public burden and associated response

time, should be directed to the: Office

of Management and Budget, Office of

Regulatory Affairs, New Executive

Office Building, Room 10235,

Washington, D.C. 20503, Attention:

Desk Officer for NIH. To request more

information on the proposed project or

to obtain a copy of the data collection

plans and instruments, contact: Carolyn

Tilley, Head, Medlars Management

Section, BSD, LO, NLM, NIH, Building

38A, Room 4N–04, 8600 Rockville Pike,

Bethesda, MD 20894, or call non-toll

free number (301) 402–1076 or E-mail

your request, including your address to:

carolynltilley@ccmail.nlm.nih.gov.

COMMENTS DUE DATE: Comments

regarding this information collection are

best assured of having their full effect if

received on or before December 12,

1997.

Dated: November 3, 1997.

Donald C. Poppke,

Executive Officer, NLM.

[FR Doc. 97–29669 Filed 11–10–97; 8:45 am]

BILLING CODE 4410–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Pursuant to Section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

President’s Cancer Panel.

This meeting will be open to the

public as indicated below, with

attendance by the public limited to

space available. Individuals who plan to

attend and need special assistance, such

as sign language interpretatin or other

reasonable accommodations, should

notify Linda Quick-Cameron,

Committee Management Officer,

National Cancer Institute, Executive

Plaza North, Room 609, 6130 Executive

Blvd., MSC 7410, Bethesda, MD 20892–

7410 (301/496–5708). A summary of the

meeting and the roster of committee

members will be provided upon request.

Other information pertaining to the

meeting may be obtained from the

contact person indicated below.

Committee Name: President’s Cancer

Panel.

Date: November 21, 1997.

Place: Moffitt Cancer Center, Research

Center (Across from Cancer Center), 12902

Magnolia Drive, Tampa, FL 33612.

Open: 8:00 a.m. to Adjournment.

Agenda: Concerns of special populations

in the National Cancer Program: